Furthermore, studies in mouse models and patient-derived samples have shown that JUP acts as an enabling factor for disease initiation and progression of BCR::ABL1-positive B-ALL in an MYC-dependent manner by augmenting and enforcing BIRC5 expression [26]. The gene discussed is MYC; the disease is precursor B-cell acute lymphoblastic leukemia.